Axitinib Accord

Axitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Accord Healthcare S.L.U. and is intended for oral use.

Axitinib Accord is primarily used in the treatment of advanced renal cell carcinoma, a type of kidney cancer. It may also be prescribed for other types of cancer as determined by a healthcare provider. The medication works by targeting specific proteins involved in the growth and spread of cancer cells. Patients often wonder, 'What is Axitinib used for?' and the answer typically involves its role in managing advanced cancers.

Common effects of Axitinib Accord may include fatigue, diarrhea, and high blood pressure. Some users may also experience decreased appetite, nausea, and vomiting. These effects can vary from person to person and may not affect everyone who takes the medication.

Axitinib Accord should be handled with care and stored as directed. It is important to follow the instructions provided by the healthcare provider or pharmacist. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Axitinib Accord may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of this medication.